Nabovati, Ehsan
Rangraz Jeddi, Fatemeh
Tabatabaeizadeh, Seyed Mashallah
Hamidi, Rahele http://orcid.org/0000-0002-9857-9633
Sharif, Reihane
Article History
Received: 7 April 2022
Revised: 16 September 2022
Accepted: 3 October 2022
First Online: 31 October 2022
Declarations
:
: Funding.
: This study was supported by a grant from Kashan University of Medical Sciences Research Council (Number: 96104) and did not receive any grants from non-profit organizations and funding agencies in the public and commercial sectors.
: The authors declare that they have no competing interests.
: The present study was approved by the Ethics Committee of Kashan University of Medical Sciences (Code: IR.KAUMS.NUHEPM.REC.1396.21). The researcher obtained the necessary permission to conduct the study from the university officials. The study objectives were explained to the participants and their informed consent was obtained. The participants’ independence was maintained by assuring them about their voluntary participation, non-participation, and withdrawal. Data were confidentially kept by the researcher and were only used for the study purposes. Regarding the use of scientific references and translation, copyrights were entirely observed.
: Type II diabetes mellitus (T2DM), World Health Organization (WHO), electronic Health (eHealth), mobile Health (mHealth), Applications (apps), Information Technology (IT), electronic Health (eHealth), Content Validity Index (CVI), Content Validity Ratio (CVR), Statistical Package for Social Sciences (SPSS), Graphical User Interface (GUI), Questionnaire for User Interaction Satisfaction (QUIS).